David E. Coutant

Comparison of the Pharmacokinetics and Pharmacodynamics of LY2963016 Insulin Glargine and EU- and US-Approved Versions of Lantus Insulin Glargine in Healthy Subjects: Three Randomized Euglycemic Clamp Studies

Helle Linnebjerg, Eric Chen Quin Lam, Mary Seger et al. · Diabetes Care · 2015 · 95 citations

Medicine, Pharmacokinetics, Pharmacology +14

Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study

Tim Heise, Helle Linnebjerg, David E. Coutant et al. · Diabetes Obesity and Metabolism · 2020 · 65 citations · Full text

Medicine, Clinical Pharmacy, Pharmacology +6

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial

Helle Linnebjerg, Qianyi Zhang, Elizabeth LaBell et al. · Clinical Pharmacokinetics · 2020 · 57 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Immobilized Porphyrins as Versatile Stationary Phases in Liquid Chromatography

Jie Xiao, C. E. Kibbey, David E. Coutant et al. · Journal of Liquid Chromatography & Related Technologies · 1996 · 37 citations

Pharmacy, Chemical Engineering, Chemistry +17

The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron

Kyle W. Sloop, Amy L. Cox, David B. Wainscott et al. · Science Translational Medicine · 2024 · 34 citations

Medicine, Pharmacology, Pharmacotherapy +17